Navigation Links
Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
Date:4/3/2008

d FOSRENOL in the US alone.

FOSRENOL has the most extensive long-term safety data package of any phosphate binder and is generally well tolerated. Trials involving patients treated with FOSRENOL showed sustained serum phosphorus reduction in a majority of patients, with some patients being followed over a six-year duration.

FOSRENOL is now available in 25 countries, including Spain, Canada, France, Germany, Italy, and the UK, and continues to be launched in new markets around the world.

Important Safety Information

-- The most common adverse events were gastrointestinal, such as nausea

and vomiting, and generally abated over time with continued dosing.

-- The most common side effects leading to discontinuation in clinical

trials were gastrointestinal events (nausea, vomiting, and diarrhea).

-- Other side effects reported in trials included dialysis graft

complications, headache, abdominal pain, and hypotension.

-- Although studies were not designed to detect differences in risk of

fracture and mortality, there were no differences demonstrated in

patients treated with FOSRENOL compared to alternative therapy for up

to 3 years.

-- The duration of treatment exposure and time of observation in the

clinical program were too short to conclude that FOSRENOL does not

affect the risk of fracture or mortality beyond 3 years.

-- While lanthanum has been shown to accumulate in the GI tract, liver

and bone in animals, the clinical significance in humans is unknown.

-- Patients with acute peptic ulcer, ulcerative colitis, Crohn's disease,

or bowel obstruction were not included in FOSRENOL clinical studies.

Caution should be used in patients with these conditions.

-- FOSRENOL should not be taken by patients who are nursing or pregnant.

-- FOSRENOL should not be taken by patie
'/>"/>

SOURCE Shire Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
2. New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion
3. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
4. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
5. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
6. Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss
7. Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action
8. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
9. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
10. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
11. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... CHAPEL HILL, N.C. , Dec. 23, 2014 /PRNewswire/ ... marketplace success. As the key link between the medical ... will grow even more in the coming years as ... relationships. According to research by benchmarking ... and MSLs can gain an important edge is by ...
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... "US Self-monitoring Blood Glucose Market" report to ... This market insight focuses on the developments ... the United States . Reimbursement analysis and the ... analyses for more than 73 SMBG meters have been ...
(Date:12/22/2014)... 2014 Cyberonics, Inc. (NASDAQ: CYBX ), ... management of epilepsy, today announced it will participate in the ... January 14, 2015, in San Francisco . ... Executive Officer, will speak at 11:00 AM Pacific Time.  A ... clicking on the Investor Relations link on the Cyberonics home ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2US Self-monitoring Blood Glucose Market 2
... (Nasdaq: NVAX ) a clinical-stage vaccine company, ... of Novavax will be presenting at the Stifel Nicolaus ... 17, 2010 at 10:20am local time at the Four ... company overview, outline its competitive position and characterize Novavax,s ...
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ... million shares of its common stock pursuant to an effective ... Inc. is the sole book-running manager of the offering and ... to purchase up to 1,245,000 additional shares. Halozyme intends to ...
Cached Medicine Technology:Halozyme Therapeutics Announces Public Offering of Common Stock 2Halozyme Therapeutics Announces Public Offering of Common Stock 3
(Date:12/25/2014)... Recently, BellasDress has launched its Christmas ... BellasDress has chosen their best-selling lace wedding dresses, vintage ... holiday season. , Now, BellasDress.com features popular women’s ... at discount prices. The business hopes everyone can have ... , “All our elegant products are made with ...
(Date:12/25/2014)... When head lice hits a home or school, parents ... rid of it while keeping it from taking over the ... the solution right in their neighborhood: Lice Troopers . ... full spectrum head lice screening and treatment services to families ... Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , ...
(Date:12/25/2014)... -- The risk of burns from fires and cooking ... be extra cautious, an expert says. "Between Thanksgiving ... in patients coming in with burns," said Dr. Steven ... Burn Center of Stony Brook University Hospital in New ... but if not careful, could quickly turn tragic," Sandoval ...
(Date:12/25/2014)... Thompson HealthDay Reporter WEDNESDAY, ... in on a "fountain of youth" drug that can delay ... adults, a new study suggests. Seniors received a significant ... targets a genetic signaling pathway linked to aging and immune ... The experimental medication, a version of the drug rapamycin, ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch as ... coolest mobile applications on the iOS, Android, and Windows markets. ... conducted the app review and shared with viewers how this ... The old saying goes, “A picture says a thousand words.” ... describe a single image, because each picture holds a unique ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... ... can save money, get a policy that matches their needs and stay within their budget., ... Miami, Florida (PRWEB) June 28, 2010 -- ... customers choose how much they want to pay for a term life insurance policy. With ...
... By Steven Reinberg HealthDay Reporter , SUNDAY, ... pancreas technology can help diabetics gain greater blood sugar control ... had wine for dinner. The promise of this emerging ... monitor their blood sugar levels by letting a computer program ...
... ... provider (hosted PBX) in Los Angeles is on a mission to help non profit organizations ... up for a new calling plan with the company in the coming months. , ... Los Angeles, CA (PRWEB) June 28, ...
... ... people with Peripheral Arterial Disease . Most had no idea they had it. Thank ... ... 15th press release, it was reported that Minnesota Congressman Erik Paulsen (MN-03) proposed a resolution ...
... The First New ... Providers to Appeal Claim Denials and Delays, to Comply with New Health Reform Law, Going ... , ... June 28, 2010 -- ERISAclaim.com announced the nation,s first new Health Reform Law, PPACA, Claim ...
... ... exclusive U.S. distributors of The Yantra Mat, release The Yantra Kit—a complete, three-part, self-treatment ... acupressure belts (for arms/legs/body) and acupressure rings (for fingers). , ... New York, NY (Vocus) June 28, 2010 ...
Cached Medicine News:Health News:Online Broker Lets Consumers Choose The Price of Life Insurance 2Health News:Online Broker Lets Consumers Choose The Price of Life Insurance 3Health News:Artificial Pancreas Continues to Show Promise 2Health News:Artificial Pancreas Continues to Show Promise 3Health News:Artificial Pancreas Continues to Show Promise 4Health News:UniVoIP is Donating Free VoIP Phones to Non-profit Organizations in California 2Health News:UniVoIP is Donating Free VoIP Phones to Non-profit Organizations in California 3Health News:Life Line Screening Applauds Rep. Paulsen on P.A.D. Resolution 2Health News:New Health Reform Law Claim Denial Appeal Book Announced for Healthcare Providers to Comply with New PPACA Deadline - 09/23/2010 2Health News:New Health Reform Law Claim Denial Appeal Book Announced for Healthcare Providers to Comply with New PPACA Deadline - 09/23/2010 3Health News:New Health Reform Law Claim Denial Appeal Book Announced for Healthcare Providers to Comply with New PPACA Deadline - 09/23/2010 4Health News:Yantra Mat USA Introduces the Yantra Kit: Bringing the Health Benefits of Acupressure to the Entire Body 2
Anatomically designed 3 cervical foam collar...
This model utilizes the Malibu Soft Cervical Collar with a Thoracic Extension....
... Occipital Mandibular Immobilizer) A completely adjustable ... or hypertension positioning and immobilization. Offers ... Philadelphia™ collar and a halo-type brace.,Mandibular ... Removable chin plate allows for patient ...
... Wrap® Economy Universal Cervical ... with synthtic white stockinette ... for flexion or extension. ... air dry. 3"H.,Universal size ...
Medicine Products: